It is possible that the knockdown of copper chaperone antioxidant-1 inhibits copper-stimulated proliferation of NSCLC [36] and that the copper transporter ATP7A is correlated with platinum chemotherapy resistance in NSCLC [37]. The gene discussed is ATOX1; the disease is non-small cell lung carcinoma.